-
DEVCOM CBC, Chemring Sign Patent Agreement for TACBIO® 2 Biosensor
08 May 2025 18:26 GMT
ABERDEEN PROVING GROUND, MARYLAND, UNITED STATES
05.07.2025
Aberdeen Proving Ground, MD – The U.S. Combat Capabilities Development Command Chemical Biological Center (DEVCOM CBC) formally signed a non-exclusive license agreement with Chemring Sensors and …
-
Patenting Microbial Products: Pitfalls, Value, and Special Concerns
08 May 2025 14:59 GMT
… discusses some problems with patenting microbial products, and … many inventions are patented involving unexpected properties … mechanical devices or straightforward chemical mixtures. Microbial products … was patented, which was a naturally occurring chemical in …
-
Korean researchers patent new autotaxin inhibitors
07 May 2025 15:45 GMT
Gastrointestinal
Scientists at Arontier Co. Ltd. and Korea Research Institute of Chemical Technology have disclosed ectonucleotide pyrophosphatase/phosphodiesterase 2 (ENPP2; autotaxin) inhibitors reported to be useful for the treatment of hepatic …
-
Kemin Industries receives US patent
07 May 2025 15:41 GMT
DES MOINES, IOWA — Kemin Industries has been granted a patent by the United States Patent and Trademark Office (USPTO) for its brine that contains proteins that are free of salt and phosphates. The USPTO issued US Patent No. 12,245,618 B2, entitled “Brine …
-
Tropical Agro Unveils Patented Paddy Insecticide
07 May 2025 09:52 GMT
Advertisement
Tropical Agro, an agro-input innovator based in Chennai, has launched a patented granular insecticide designed to target two of the most destructive pests in paddy cultivation—stem borer and leaf folder. Branded as Tag Stem Lee, the …
-
USPTO grants two additional patents to Moleculin’s drug candidate
06 May 2025 11:44 GMT
The US Patent and Trademark Office (USPTO) has granted Moleculin Biotech two additional patents with claims covering the company’s drug candidate Annamycin.
These patents have a base patent term extending until June 2040.
This is contingent upon the …
-
Moleculin Bolsters Annamycin Intellectual Property Portfolio with Granting of Two New U.S. Patents
05 May 2025 12:45 GMT
Company continues to expand global IP coverage and claims to major markets, now extending to June 2040 HOUSTON, May 05, 2025 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a late-stage pharmaceutical company …
-
Pharmaceutical Chemicals Market Report 2025 | Regulatory Compliance Spurs Demand For High-Quality Pharmaceutical Chemicals
05 May 2025 09:48 GMT
… the market. Innovations in chemical synthesis improve efficiency, while … specialized chemicals. The growing market for generics and biosimilars post-patent … boosting chemical demand. Report Scope
The report analyzes the Pharmaceutical Chemicals market …
-
Alterity Therapeutics Announces Multiple Oral and Poster Presentations to be Featured at the International MSA Congress
07 May 2025 12:16 GMT
… broad drug discovery platform generating patentable chemical compounds to treat the underlying …
-
Koppö Energia decides for thyssenkrupp Uhde’s green methanol technology
06 May 2025 12:10 GMT
Koppö Energia Oy has chosen uhde® green methanol technology and ordered a front end engineering design (FEED) from thyssenkrupp Uhde.
The planned e-methanol plant is part of a power-to-x (P2X) project developed by Koppö Energia in Kristinestad, Finland. …